Sensyne Health Plc (LON: SENS) has signed a five-year non-exclusive SRA (Strategic Research Agreement) with Milton Keynes University Hospital NHS Foundation Trust (MKUH).
- The agreement with MKUH will facilitate the ethical application of clinical AI research to enhance patient care and step up research into new medicines.
- As per the agreement, MKUH will get 1,428,571 ordinary shares in the company representing 1.1 per cent of the existing issued share capital.
- The company also has SRAs with South Warwickshire NHS Foundation Trust, Wye Valley and George Eliot NHS Trusts, Chelsea & Westminster Hospitals NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust.
- On 26 October 2020, the stocks of the company surged by 5.66% from its previous closing, hovering at around GBX 112.00 at 08:13 AM GMT+1.